Careers  |  Sign In  |  Register

Latest in Professional Development

Merck & Co. Inc.'s immune-stimulating melanoma drug, Keytruda (pembrolizumab) has received FDA approval, a Reuters article says. The drug, which is designed to stimulate the immune system to fight off cancer by blocking PD-1 proteins, is the first of its kind to receive approval. Melanoma is the...
For women with breast cancer, a month or more of daily radiation treatment is common, however, according to an article published in CBS News, weekly treatment may be just as effective. This new, less frequent treatment option yields similar results, compensating for the six days off from radiation by...
General Electric's 3-D mammography device, SenoClaire, has received FDA approval, a Reuters article reports. The device, which is designed to detect breast cancer through the combination of low radiation X-rays from multiple angles, offers a more comprehensive and complete mammogram compared to the...